Akèy › Kansè Utèrin › Missouri
Etid klinik pou Kansè Utèrin nan Missouri
5 etid pou Kansè Utèrin ap chèche patisipan nan sit nan Missouri.
Vil nan Missouri
Tèks ofisyèl etid la (Anglè)
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Research Site, Springfield
- Research Site, St Louis
Ap rekriteFaz 3
Laj 18 ak plis · Fanm · Mizajou Sep 3, 2026 · NCT06989112Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
- Washington University School of Medicine, St Louis
Ap rekriteEtid obsèvasyon
Laj 18 a 50 · Fanm · Mizajou Sep 2, 2026 · NCT06904365Investigations of Reproductive Cancers in Women
- Washington University School of Medicine, St Louis
Ap rekriteEtid obsèvasyon
Laj 45 a 100 · Fanm · Mizajou Aug 17, 2026 · NCT06527157A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Mosaic Life Care at Saint Joseph - Medical Center, Saint Joseph
Ap rekriteFaz 2
Laj 8 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT05503797Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer
- Washington University School of Medicine, St Louis
Ap rekriteFaz 1
Laj 18 ak plis · Fanm · Mizajou Dec 11, 2025 · NCT06795009Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.